BETA ADRENERGIC RECEPTORS--REGULATION IN CILIARY BODY
β 肾上腺素能受体 - 睫状体的调节
基本信息
- 批准号:2378030
- 负责人:
- 金额:$ 11.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-03-01 至 2001-02-28
- 项目状态:已结题
- 来源:
- 关键词:G protein RNase protection assay adenylate cyclase beta adrenergic receptor binding proteins cell biology cell type confocal scanning microscopy fluorescence microscopy genetic transcription glaucoma human tissue image processing in situ hybridization intraocular fluid messenger RNA molecular biology northern blottings phase contrast microscopy polymerase chain reaction receptor binding receptor coupling receptor expression tissue /cell culture uvea ciliary body
项目摘要
Glaucoma is the premier cause of blindness in African Americans and the
second leading cause of blindness in the United States. While the mainstay
of treatment is beta-adrenergic receptor (beta-AR) antagonists which
suppress aqueous secretion, the signaling pathways regulating the ion
channels and transporters coupled to aqueous secretion are appreciated
primarily at a protein level. There is little understanding of the beta-AR
receptors in the aqueous pathway at the molecular level. Much remains to
be learned about "upstream (e.g., transcriptional, translational, and
post-translational events) and "downstream" (e.g., distribution,
phosphorylation, and sequestration) pathways relative to any of the G
protein-coupled receptors known at the membrane level of the ciliary
epithelial bilayer.
The physician scientist candidate's long-term objective is to understand
the molecular and cellular biology of G protein-coupled receptors
mediating aqueous secretion. She proposes to learn the tools of these
disciplines and to accomplish the following four specific aims: (I) The
potential heterogeneous expression of the beta-AR (i.e., beta1, beta2, and
beta3) in nonpigmented ciliary epithelium (NPE) will be studied by
ribonuclease protection assay. (2) The correlation of transcript
heterogeneity in these cells with protein expression will be assessed by
radioligand binding and adenylate cyclase assays. These molecular,
pharmacological, and biochemical studies will be conducted in 5V40-
transformed human NPE and confirmed in nontransformed NPE cultures. (3)
One of the principal mechanisms of steroid hormone action is modulating
gene transcription; the 5'-flanking regions of the beta1- and beta2-AR
genes have great homology to a glucocorticoid responsive element consensus
sequence. A similar beta-AR regulatory process is hypothesized in NPE.
Transcriptional up-regulation of these receptors may contribute to the
pathophysiology of steroid-induced glaucoma. beta-AR transcript levels and
protein expression will be assessed in NPE-cells exposed to dexamethasone.
(4) Since the localization of the beta-AR has not yet been determined, in
situ hybridization will be used to identify the cell types expressing
beta-AR transcripts within the ciliary epithelial bilayer and other
regions of the anterior segment. At the level of the plasma membrane, the
cellular distribution of the beta-AR is expected to be polarized given the
secretory nature of the ciliary bilayer. This receptor "trafficking"
pattern will be examined by confocal microscopy in cells and epithelial
bilayer explants labeled with fluorescein-conjugated ligands, epitope-
labeled receptors, or subtype specific antibodies; such studies reflect
the physiological significance in native tissue.
These proposed studies will lead to a better appreciation for the
fundamental mechanisms that regulate aqueous production and that may play
a role in the pathophysiology of glaucoma.
青光眼是非裔美国人和非裔美国人失明的首要原因
在美国是导致失明的第二大原因。虽然是中流砥柱
治疗的主要药物是β-肾上腺素能受体(β-AR)拮抗剂
抑制房水分泌,调节离子的信号通路
与水性分泌物偶联的通道和转运蛋白受到赞赏
主要是在蛋白质水平。对 beta-AR 知之甚少
分子水平上水通路中的受体。还有很多工作要做
了解“上游”(例如转录、翻译和
翻译后事件)和“下游”(例如,分布,
与任何 G 相关的磷酸化和隔离)途径
睫状体膜水平已知的蛋白质偶联受体
上皮双层。
医师科学家候选人的长期目标是了解
G蛋白偶联受体的分子和细胞生物学
介导房水分泌。她建议学习这些工具
学科建设,实现以下四个具体目标:
β-AR 的潜在异质表达(即 beta1、beta2 和
beta3)在非色素性睫状上皮(NPE)中的研究将通过
核糖核酸酶保护测定。 (2) 转录本的相关性
这些细胞中蛋白质表达的异质性将通过以下方式进行评估
放射性配体结合和腺苷酸环化酶测定。这些分子,
药理学和生化研究将在5V40-中进行
转化的人类 NPE 并在非转化的 NPE 培养物中得到证实。 (3)
类固醇激素作用的主要机制之一是调节
基因转录; beta1- 和 beta2-AR 的 5' 侧翼区域
基因与糖皮质激素反应元件共识具有很大的同源性
顺序。 NPE 中假设有类似的 β-AR 调节过程。
这些受体的转录上调可能有助于
类固醇引起的青光眼的病理生理学。 β-AR 转录水平和
将评估暴露于地塞米松的 NPE 细胞中的蛋白质表达。
(4) 由于β-AR的定位尚未确定,
原位杂交将用于鉴定表达的细胞类型
睫状上皮双层和其他区域内的β-AR转录物
眼前节区域。在质膜水平上,
考虑到 β-AR 的细胞分布预计会出现两极分化
睫状双层的分泌性质。这种受体“贩卖”
将通过共聚焦显微镜检查细胞和上皮细胞的模式
用荧光素缀合的配体、表位标记的双层外植体
标记受体,或亚型特异性抗体;此类研究反映
在天然组织中的生理意义。
这些拟议的研究将导致人们更好地认识
调节水生产的基本机制,可能发挥作用
在青光眼的病理生理学中发挥作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sayoko E Moroi其他文献
Sayoko E Moroi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sayoko E Moroi', 18)}}的其他基金
The Ohio State University Vision Sciences Research Core Program (OSU-VSRCP)
俄亥俄州立大学视觉科学研究核心计划 (OSU-VSRCP)
- 批准号:
10707323 - 财政年份:2022
- 资助金额:
$ 11.04万 - 项目类别:
Aqueous Humor Dynamic Components that Determine Intraocular Pressure Variance
决定眼压变化的房水动态成分
- 批准号:
10483194 - 财政年份:2012
- 资助金额:
$ 11.04万 - 项目类别:
Aqueous Humor Dynamic Components that Determine Intraocular Pressure Variance
决定眼压变化的房水动态成分
- 批准号:
8219967 - 财政年份:2012
- 资助金额:
$ 11.04万 - 项目类别:
Aqueous Humor Dynamic Components that Determine Intraocular Pressure Variance
决定眼压变化的房水动态成分
- 批准号:
8438381 - 财政年份:2012
- 资助金额:
$ 11.04万 - 项目类别:
Aqueous Humor Dynamic Components that Determine Intraocular Pressure Variance
决定眼压变化的房水动态成分
- 批准号:
10248378 - 财政年份:2012
- 资助金额:
$ 11.04万 - 项目类别:
Aqueous Humor Dynamic Components that Determine Intraocular Pressure Variance
决定眼压变化的房水动态成分
- 批准号:
8616758 - 财政年份:2012
- 资助金额:
$ 11.04万 - 项目类别:
Aqueous Humor Dynamic Components that Determine Intraocular Pressure Variance
决定眼压变化的房水动态成分
- 批准号:
8548511 - 财政年份:2012
- 资助金额:
$ 11.04万 - 项目类别:
Aqueous Humor Dynamic Components that Determine Intraocular Pressure Variance
决定眼压变化的房水动态成分
- 批准号:
10004052 - 财政年份:2012
- 资助金额:
$ 11.04万 - 项目类别:
相似海外基金
STEROID REGULATION OF B-ADRENORECEPTOR GENES IN OBESITY
肥胖中 B 肾上腺素受体基因的类固醇调节
- 批准号:
2862816 - 财政年份:1998
- 资助金额:
$ 11.04万 - 项目类别:
BETA ADRENERGIC RECEPTORS--REGULATION IN CILIARY BODY
β 肾上腺素能受体 - 睫状体的调节
- 批准号:
2668358 - 财政年份:1996
- 资助金额:
$ 11.04万 - 项目类别:
BETA ADRENERGIC RECEPTORS--REGULATION IN CILIARY BODY
β 肾上腺素能受体 - 睫状体的调节
- 批准号:
2882860 - 财政年份:1996
- 资助金额:
$ 11.04万 - 项目类别:
BETA ADRENERGIC RECEPTORS--REGULATION IN CILIARY BODY
β 肾上腺素能受体 - 睫状体的调节
- 批准号:
6164629 - 财政年份:1996
- 资助金额:
$ 11.04万 - 项目类别:
STEROID REGULATION OF B-ADRENORECEPTOR GENES IN OBESITY
肥胖中 B 肾上腺素受体基因的类固醇调节
- 批准号:
2146042 - 财政年份:1994
- 资助金额:
$ 11.04万 - 项目类别: